文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Blockade of spinal dopamine D1/D2 receptor suppresses activation of NMDA receptor through Gαq and Src kinase to attenuate chronic bone cancer pain.

作者信息

Dai Wen-Ling, Bao Yi-Ni, Fan Ji-Fa, Ma Bin, Li Shan-Shan, Zhao Wan-Li, Yu Bo-Yang, Liu Ji-Hua

机构信息

Jiangsu Key Laboratory of TCM Evaluation and Translational Research, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu 211198, China.

State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu 210009, China.

出版信息

J Adv Res. 2020 Aug 13;28:139-148. doi: 10.1016/j.jare.2020.08.005. eCollection 2021 Feb.


DOI:10.1016/j.jare.2020.08.005
PMID:33364051
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7753228/
Abstract

INTRODUCTION: Spinal N-methyl-D-aspartate receptor (NMDAR) is vital in chronic pain, while NMDAR antagonists have severe side effects. NMDAR has been reported to be controlled by G protein coupled receptors (GPCRs), which might present new therapeutic targets to attenuate chronic pain. Dopamine receptors which belong to GPCRs have been reported could modulate the NMDA-mediated currents, while their exact effects on NMDAR in chronic bone cancer pain have not been elucidated. OBJECTIVES: This study was aim to explore the effects and mechanisms of dopamine D1 receptor (D1DR) and D2 receptor (D2DR) on NMDAR in chronic bone cancer pain. METHODS: A model for bone cancer pain was established using intra-tibia bone cavity tumor cell implantation (TCI) of Walker 256 in rats. The nociception was assessed by Von Frey assay. A range of techniques including the fluorescent imaging plate reader, western blotting, and immunofluorescence were used to detect cell signaling pathways. Primary cultures of spinal neurons were used for in vitro evaluation. RESULTS: Both D1DR and D2DR antagonists decreased NMDA-induced upregulation of Ca oscillations in primary culture spinal neurons. Additionally, D1DR/D2DR antagonists inhibited spinal Calcitonin Gene-Related Peptide (CGRP) and c-Fos expression and alleviated bone cancer pain induced by TCI which could both be reversed by NMDA. And D1DR/D2DR antagonists decreased p-NR1, p-NR2B, and Gαq protein, p-Src expression. Both Gαq protein and Src inhibitors attenuated TCI-induced bone cancer pain, which also be reversed by NMDA. The Gαq protein inhibitor decreased p-Src expression. In addition, D1DR/D2DR antagonists, Src, and Gαq inhibitors inhibited spinal mitogen-activated protein kinase (MAPK) expression in TCI rats, which could be reversed by NMDA. CONCLUSIONS: Spinal D1DR/D2DR inhibition eliminated NMDAR-mediated spinal neuron activation through Src kinase in a Gαq-protein-dependent manner to attenuate TCI-induced bone cancer pain, which might present a new therapeutic strategy for bone cancer pain.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eed2/7753228/a869f59c8807/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eed2/7753228/d4ab7b947582/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eed2/7753228/13655c712bb5/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eed2/7753228/a78127d145de/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eed2/7753228/489270cda463/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eed2/7753228/e4163a3e80c3/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eed2/7753228/a869f59c8807/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eed2/7753228/d4ab7b947582/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eed2/7753228/13655c712bb5/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eed2/7753228/a78127d145de/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eed2/7753228/489270cda463/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eed2/7753228/e4163a3e80c3/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eed2/7753228/a869f59c8807/gr5.jpg

相似文献

[1]
Blockade of spinal dopamine D1/D2 receptor suppresses activation of NMDA receptor through Gαq and Src kinase to attenuate chronic bone cancer pain.

J Adv Res. 2020-8-13

[2]
Blockade of spinal dopamine D1/D2 receptor heteromers by -Corydalmine suppressed calcium signaling cascade in spinal neurons to alleviate bone cancer pain in rats.

J Cancer. 2024-1-1

[3]
The dopamine D1-D2DR complex in the rat spinal cord promotes neuropathic pain by increasing neuronal excitability after chronic constriction injury.

Exp Mol Med. 2021-2

[4]
Selective blockade of spinal D2DR by levo-corydalmine attenuates morphine tolerance via suppressing PI3K/Akt-MAPK signaling in a MOR-dependent manner.

Exp Mol Med. 2018-11-14

[5]
Simultaneous inhibition of NMDA and mGlu1/5 receptors by levo-corydalmine in rat spinal cord attenuates bone cancer pain.

Int J Cancer. 2017-8-15

[6]
IL-18 Contributes to Bone Cancer Pain by Regulating Glia Cells and Neuron Interaction.

J Pain. 2017-12-12

[7]
Extrasynaptic targeting of NMDA receptors following D1 dopamine receptor activation and cocaine self-administration.

J Neurosci. 2013-5-29

[8]
Chemokine receptor CCR2 contributes to neuropathic pain and the associated depression via increasing NR2B-mediated currents in both D1 and D2 dopamine receptor-containing medium spiny neurons in the nucleus accumbens shell.

Neuropsychopharmacology. 2018-6-11

[9]
Modulation of NMDA receptors by pituitary adenylate cyclase activating peptide in CA1 neurons requires G alpha q, protein kinase C, and activation of Src.

J Neurosci. 2005-12-7

[10]
Blockade of neuronal dopamine D2 receptor attenuates morphine tolerance in mice spinal cord.

Sci Rep. 2016-12-22

引用本文的文献

[1]
Bone marrow mesenchymal stem cells improve bone cancer pain by inhibiting p38MAPK phosphorylation and microglia activation.

Korean J Pain. 2025-4-1

[2]
Neuroscience of cancer: unraveling the complex interplay between the nervous system, the tumor and the tumor immune microenvironment.

Mol Cancer. 2025-1-17

[3]
Analgesic Effect of Dehydrocorydaline on Chronic Constriction Injury-Induced Neuropathic Pain via Alleviating Neuroinflammation.

Chin J Integr Med. 2025-6

[4]
Neuroprotection of Kaji-Ichigoside F1 via the BDNF/Akt/mTOR Signaling Pathways against NMDA-Induced Neurotoxicity.

Int J Mol Sci. 2022-12-18

[5]
Emerging Materials, Wearables, and Diagnostic Advancements in Therapeutic Treatment of Brain Diseases.

Biosensors (Basel). 2022-12-16

[6]
Dopamine receptor D2 regulates GLUA1-containing AMPA receptor trafficking and central sensitization through the PI3K signaling pathway in a male rat model of chronic migraine.

J Headache Pain. 2022-8-10

[7]
Role of N-Methyl-D-Aspartate Receptor NR2B Subunit in Inflammatory Arthritis-Induced Chronic Pain and Peripheral Sensitized Neuropathic Pain: A Systematic Review.

J Pain Res. 2022-7-18

[8]
Electroacupuncture Alleviates Anxiety-Like Behaviors Induced by Chronic Neuropathic Pain via Regulating Different Dopamine Receptors of the Basolateral Amygdala.

Mol Neurobiol. 2022-9

[9]
Analgesic effect of electroacupuncture on bone cancer pain in rat model: the role of peripheral P2X3 receptor.

Purinergic Signal. 2023-3

[10]
Roles of Phosphorylation of N-Methyl-D-Aspartate Receptor in Chronic Pain.

Cell Mol Neurobiol. 2023-1

本文引用的文献

[1]
An exploratory randomized-controlled trial of the efficacy of the Src-kinase inhibitor saracatinib as a novel analgesic for cancer-induced bone pain.

J Bone Oncol. 2019-9-18

[2]
CNS myeloid cells critically regulate heat hyperalgesia.

J Clin Invest. 2018-5-21

[3]
NMDA Receptors in the Central Nervous System.

Methods Mol Biol. 2017

[4]
Fos Protein as a Marker of Neuronal Activity: a Useful Tool in the Study of the Mechanism of Action of Natural Products with Analgesic Activity.

Mol Neurobiol. 2017-7-10

[5]
The Src family kinase inhibitor dasatinib delays pain-related behaviour and conserves bone in a rat model of cancer-induced bone pain.

Sci Rep. 2017-7-6

[6]
Simultaneous inhibition of NMDA and mGlu1/5 receptors by levo-corydalmine in rat spinal cord attenuates bone cancer pain.

Int J Cancer. 2017-8-15

[7]
Dopamine promotes NMDA receptor hypofunction in the retina through D receptor-mediated Csk activation, Src inhibition and decrease of GluN2B phosphorylation.

Sci Rep. 2017-1-18

[8]
The Walker 256 Breast Cancer Cell- Induced Bone Pain Model in Rats.

Front Pharmacol. 2016-8-31

[9]
Effects of Src-kinase inhibition in cancer-induced bone pain.

Mol Pain. 2016-4-18

[10]
Sigma-1 Receptor Antagonist BD1047 Reduces Mechanical Allodynia in a Rat Model of Bone Cancer Pain through the Inhibition of Spinal NR1 Phosphorylation and Microglia Activation.

Mediators Inflamm. 2015

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索